SAPT Versus DAPT in Incomplete Revascularization After CABG

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 800 participants.

Also called NCT03789916

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 800 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03789916
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03789916. Randomized; no masking; primary purpose treatment. Start 2019-01-02 (actual); primary completion 2021-08-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SAPT Versus DAPT in Incomplete Revascularization After CABG
Acronym
SDAT-IRC
Intervention (Drug)
Ticagrelor
Intervention (Drug)
acetylsalicylic acid
Lead sponsor
Campus Bio-Medico University (class: other)

Record details

Record id
cardio:ct-nct03789916
Content hash
0461a403b475ef7911a56b0041ec491597a9972c7c09fa18a8b70259b77fae1d